FDA gives OK for autism cord blood stem cell study

10/15/2012 | Examiner.com

The FDA has approved a study that will use the stored umbilical cord blood of children with autism to treat the condition. The study will be undertaken by researchers at the Sutter Neuroscience Institute in California and will involve 30 participants. Researchers will look for an effect on language and behavior.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC